Does omega 3 help lower cholesterol
Pro Research Analysisby 
Searched over 200M research papers
The Impact of Omega-3 Fatty Acids on Cholesterol Levels
Introduction to Omega-3 Fatty Acids and Cholesterol
Omega-3 fatty acids, primarily found in fish oil, have been extensively studied for their potential health benefits, particularly in cardiovascular health. One of the key areas of interest is their effect on cholesterol levels, which are critical markers for cardiovascular disease risk.
Omega-3 and Total Cholesterol Reduction
Several studies have demonstrated that omega-3 fatty acids can significantly reduce total cholesterol levels. For instance, a study involving Almega®PL, an EPA-rich extract from the microalga Nannochloropsis, showed a significant decrease in total cholesterol levels in healthy individuals after 12 weeks of supplementation1. This reduction was primarily attributed to a 25% decrease in very-low-density lipoprotein cholesterol (VLDL), without a corresponding increase in low-density lipoprotein cholesterol (LDL), highlighting the potential of EPA-only formulations in managing cholesterol levels.
Effects on Triglycerides and Non-HDL Cholesterol
Omega-3 fatty acids are particularly effective in lowering triglycerides, a type of fat found in the blood. A meta-analysis of 90 randomized controlled trials found a near-linear dose-response relationship between omega-3 intake and reductions in triglycerides and non-high-density lipoprotein cholesterol (non-HDL-C)2. This effect was more pronounced in individuals with hyperlipidemia and those who were overweight or obese, especially at doses greater than 2 grams per day.
Impact on LDL and HDL Cholesterol
The impact of omega-3 fatty acids on LDL and HDL cholesterol is more complex. While some studies have reported an increase in LDL cholesterol levels with omega-3 supplementation, this effect is often dose-dependent and varies with the baseline triglyceride levels of the individuals5 7. For example, a systematic review found that fish oil consumption led to a modest increase in LDL cholesterol but also improved HDL cholesterol levels5. Another study noted that omega-3 fatty acids improved the functionality of HDL, enhancing its cardioprotective properties9.
Specific Populations: Type 2 Diabetes and Hypertriglyceridemia
In individuals with type 2 diabetes, omega-3 supplementation has been shown to lower triglycerides and VLDL cholesterol, although it may slightly raise LDL cholesterol3. For those with severe hypertriglyceridemia, prescription omega-3 fatty acids have been effective in significantly reducing triglyceride levels and non-HDL cholesterol, with doses of 2 to 4 grams per day showing substantial benefits6 7.
Conclusion
Overall, omega-3 fatty acids, particularly EPA and DHA, have a beneficial impact on cholesterol levels, primarily by lowering triglycerides and non-HDL cholesterol. While they may increase LDL cholesterol in some cases, the net effect is generally positive, especially in reducing cardiovascular risk. These findings support the inclusion of omega-3 fatty acids in the diet or as supplements, particularly for individuals with elevated triglycerides or those at high risk of cardiovascular disease.
Sources and full results
Most relevant research papers on this topic
Omega-3 Eicosapentaenoic Acid (EPA) Rich Extract from the Microalga Nannochloropsis Decreases Cholesterol in Healthy Individuals: A Double-Blind, Randomized, Placebo-Controlled, Three-Month Supplementation Study
Almega®PL supplementation significantly increases EPA levels and reduces cholesterol levels in healthy individuals without increasing LDL, offering a natural EPA-only option for managing cholesterol levels.
RCT
Very Rigorous JournalAssociation Between Omega‐3 Fatty Acid Intake and Dyslipidemia: A Continuous Dose–Response Meta‐Analysis of Randomized Controlled Trials
Omega-3 fatty acid intake nearly linearly lowers triglyceride and non-high-density lipoprotein cholesterol, potentially supporting its use to prevent cardiovascular events.
Meta-AnalysisOmega-3 polyunsaturated fatty acids (PUFA) for type 2 diabetes mellitus.
Omega-3 PUFA supplementation in type 2 diabetes lowers triglycerides and VLDL cholesterol, but may raise LDL cholesterol and has no significant effect on glycemic control or fasting insulin.
Meta-Analysis
Highly CitedOmega-3 fatty acids in health and disease and in growth and development.
Omega-3 fatty acids are essential for human health, growth, and development, and should be included in all diets for optimal benefits.
Highly CitedEffects of omega-3 fatty acids on serum markers of cardiovascular disease risk: a systematic review.
Fish oil consumption reduces serum triglycerides, improves HDL cholesterol, and increases LDL cholesterol levels, but its effects on hs-CRP and ALA are inconclusive.
Systematic ReviewHighly CitedOmega-3 free fatty acids for the treatment of severe hypertriglyceridemia: the EpanoVa fOr Lowering Very high triglyceridEs (EVOLVE) trial.
Omega-3 free fatty acid capsules effectively lower triglycerides and improve cholesterol levels in individuals with severe hypertriglyceridemia when combined with a therapeutic lifestyle change diet.
RCT
Large Human TrialHighly CitedRole of Prescription Omega‐3 Fatty Acids in the Treatment of Hypertriglyceridemia
Prescription omega-3 fatty acids effectively lower very high triglyceride levels and very low-density lipoprotein cholesterol levels, with a low rate of adverse events and treatment discontinuations.
Highly CitedImpact of omega-3 fatty acids and/or plant sterol supplementation on non-HDL cholesterol levels of dyslipidemic Indian adults
Omega-3 fatty acids and plant sterol supplementation can help lower non-HDL cholesterol levels in Indian adults, potentially reducing coronary heart disease risk.
RCTLarge Human TrialOmega-3 Fatty Acids Improve Functionality of High-Density Lipoprotein in Individuals With High Cardiovascular Risk: A Randomized, Parallel, Controlled and Double-Blind Clinical Trial
Omega-3 fatty acids effectively reduce cardiovascular risk by improving HDL functionality and modifying its lipid, antioxidant, and enzyme composition in individuals with high cardiovascular risk.
RCTA HIGHLY BIOAVAILABLE OMEGA-3 FREE-FATTY ACID REDUCES NON-HIGH DENSITY LIPOPROTEIN CHOLESTEROL IN HIGH-RISK PATIENTS TREATED WITH A STATIN AND RESIDUAL HYPERTRIGLYCERIDEMIA (ESPRIT TRIAL)
Free-fatty acids to effectively lower non-HDL-c in high-risk patients treated with statins and residual hypertriglyceridemia.
Very Rigorous Journal